6533b827fe1ef96bd1286fc6
RESEARCH PRODUCT
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin
Wayne Huey-herng SheuHertzel C. GersteinAlvaro AvezumPeter J RaubenheimerGiulia FerranniniWilliam C. CushmanJonathan E. ShawNana PogosovaJeffrey L. ProbstfieldMatyas KeltaiMark LakshmananHelen M. ColhounLinda MellbinLeanne DyalPetr JanskyRafael DiazLawrence A. LeiterLars RydénFernando T LanasJan BasileMatthew C. RiddleValdis PīrāgsGilles R. DagenaisPatricio Lopez-jaramilloPrem Paissubject
medicine.medical_specialtyProportional hazards modelbusiness.industryHazard ratioType 2 diabetes030204 cardiovascular system & hematologyCardiovascular diseasemedicine.diseasePlaceboMetforminMetformin03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicineGLP-1-based therapymedicineDulaglutide030212 general & internal medicinePrediabetesMortalityMorbidityCardiology and Cardiovascular Medicinebusinessmedicine.drugdescription
Digital
year | journal | country | edition | language |
---|---|---|---|---|
2020-11-16 | European Heart Journal |